A double‐blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults
- 1 July 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 33 (7) , 904
- https://doi.org/10.1212/wnl.33.7.904
Abstract
Carbamazepine was compared with phenytoin in a double-blind study. Of 87 patients, data on 70 patients were complete and used for analysis. Patients (35) were treated with each drug. The incidence of major side effects, minor side effects and complete control (85%) was the same in both groups. A mild but significant elevation of WBC [white blood cell] count was found before initiation of drug treatment in the patients presenting with generalized convulsive seizures. Sporadically, elevations in SGOT [serum glutamic oxaloacetic transaminase] and LDH [lactate dehydrogenase] were seen; WBC counts < 4000 were reported, but these were not clinically significant.This publication has 14 references indexed in Scilit:
- Status epilepticusThe American Journal of Medicine, 1980
- Correlation Between Daily Fluctuations of Carbamazepine Serum Levels and Intermittent Side EffectsEpilepsia, 1980
- Autoinduction of carbamazepine metabolism in children examined by a stable isotope techniqueClinical Pharmacology & Therapeutics, 1980
- Carbamazepine in the Treatment of Partial Epileptic Seizures in Infants and Young Children: A Preliminary StudyEpilepsia, 1979
- Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapyClinical Pharmacology & Therapeutics, 1979
- A Month-by-Month Long-Term Study on Carbamazepine: Clinical, EEG and Pharmacological EvaluationJournal of International Medical Research, 1979
- Time course of carbamazepine self-inductionJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Carbamazepine vs PhenytoinArchives of Neurology, 1979
- Carbamazepine—A double‐blind comparison with phenytoinNeurology, 1977
- A Comparative Controlled Study Between Carbamazepine and Diphenylhydantoin in Psychomotor EpilepsyEpilepsia, 1976